Clinical outcomes after ablation and pacing therapy for atrial fibrillation - A meta-analysis | |
Article | |
关键词: QUALITY-OF-LIFE; RADIOFREQUENCY CATHETER ABLATION; ATRIOVENTRICULAR JUNCTION ABLATION; LEFT-VENTRICULAR FUNCTION; HIS-BUNDLE ABLATION; CARDIAC-PERFORMANCE; PHARMACOLOGICAL TREATMENT; HEART-FAILURE; SUDDEN-DEATH; PACEMAKER; | |
DOI : 10.1161/01.CIR.101.10.1138 | |
来源: SCIE |
【 摘 要 】
Background-Radiofrequency ablation of the atrioventricular node and permanent pacing are used for symptomatic relief in patients with medically refractory atrial fibrillation. In this study, meta-analysis was used to clarify clinical outcomes and survival after ablation and pacing therapy using data from the published literature. Methods and Results-We used 21 studies with a total of 1181 patients in the meta-analysis. All patients had medically refractory atrial tachyarrhythmias, primarily atrial fibrillation (97%). Nineteen measures of clinical outcome, encompassing quality of life, ventricular function, exercise duration, and healthcare use, were derived from the studies. The meta-analysis demonstrated significant improvement after ablation and pacing therapy in all outcome measures except fractional shortening, which demonstrated a trend toward improvement (P=0.08). Ejection fraction did show significant improvement (P<0.001). The calculated 1-year total and sudden death mortality rates after ablation and pacing therapy were 6.3% and 2.0%, respectively. Conclusions-Ablation and pacing therapy improves a broad range of clinical outcomes for patients with medically refractory atrial fibrillation. The calculated 1-year mortality rates after this therapy are low and comparable with medical therapy.
【 授权许可】
Free